New Stem Cell Study for Joint Pain
Osteoarthritis is the most common form of arthritis. Characterized by a degeneration of joint cartilage and the underlying bone, this condition affects more than 27 million Americans. Doctors at the Spine and Joint Centre of the New Jersey Pain Management Clinic are now offering many of these individuals a chance to improve their quality of life, as a new study will test a new treatment for chronic knee joint pain. The study will assess the use of Autologous adipose-derived stromal cells (ASCs), harvested from patients’ own abdominal (fat) tissue, to ease chronic joint pain. Men and women between the ages of 18 and 80, who have been diagnosed with osteoarthritis in the knee joint, will be able to participate in the study, which will be carried out over the course of about six months. The study will be administered by Dr. Damon Nato, a pain specialist at the Spine and Joint Centre. IRB-certified, the study has been approved by an independent review board. This means that the study will be monitored to ensure that patients are being treated properly and ethically. While all types of arthritis can cause a great deal of pain for patients, osteoarthritis of the knees can interfere with a patient’s ability to carry out simple, everyday tasks. It can bear severely negative consequences for a patient’s quality of life. Using stem cell therapy is a new and innovative method for managing pain caused by this condition. The procedure was first brought into the medical spotlight in 2011 when Bartolo Colón of the New York Yankees received injections of stem cells to treat his injured shoulder. He had recovered completely within a few weeks, and doctors at the Pain Management Clinic are hoping that their study will see similar results.